台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-兆豐-北高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/0805/10405060708090Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

兆豐-北高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/0900.00566.2065.00-5495-1.01%
2025/05/08367.7000.0067.3034910.61%
2025/05/07266.0500.0065.9024810.42%
2025/04/2300.00556.1056.50-5468-1.07%
2025/03/3100.00168.9067.50-1561-0.18%
2025/03/25175.6000.0076.0015940.17%
2025/03/2400.00172.5072.20-1593-0.17%
2025/03/1900.000.173.5772.60-0.1598-0.02%
2025/03/1800.00175.8575.50-1602-0.17%
2025/03/14179.5000.0077.7016170.16%
2025/03/130.581.00379.5781.00-2.5603-0.41%
2025/03/12378.7000.0077.5035850.51%
2025/03/11582.8000.0081.5055570.90%
2025/03/1000.000.276.8076.80-0.2518-0.04%
2025/03/0700.00070.1069.900496-0.01%
2025/03/0600.000.267.6067.60-0.2483-0.04%
2025/03/050.169.2000.0068.900.14840.01%
2025/02/2700.00166.2066.20-1478-0.21%
2025/02/2600.00166.4066.40-1490-0.20%
2025/02/210.168.1000.0067.800.15080.01%
2025/02/13261.1000.0062.8025740.35%
2025/02/10160.4000.0060.4015880.17%
2025/01/0800.00163.0062.00-1618-0.16%
2025/01/07164.1000.0062.8016220.16%
2025/01/0600.00165.4065.10-1623-0.16%
2025/01/02165.00163.8064.2006430.00%
2024/12/31164.5000.0064.3016690.15%
2024/12/3000.00165.8066.70-1692-0.14%
2024/12/27162.5000.0063.3016970.14%
2024/12/1600.000.156.0054.50-0.1679-0.01%
2024/12/1200.004753.3354.90-47678-6.92%
2024/12/110.155.001455.0054.90-13.9666-2.09%
2024/11/2200.00169.5073.00-1672-0.15%
2024/11/1400.00166.6069.00-1670-0.15%
2024/11/13163.2000.0064.0016520.15%
2024/11/1200.006466.3970.00-64632-10.11%
2024/10/30193.9000.0093.8016700.15%
2024/10/01297.2000.0097.2027870.25%
2024/09/301108.0000.00108.0017770.13%
2024/09/260.1135.0000.00133.000.17850.01%
2024/09/240.2165.0000.00159.000.27890.02%
2024/09/130.1180.0000.00178.000.17790.01%
2024/09/1200.000.1191.00187.50-0.1784-0.01%
2024/09/090.1185.2000.00195.000.18080.01%
2024/09/060.1195.0000.00195.000.18000.01%
2024/09/051.1210.3000.00206.001.17970.13%
2024/09/0200.001224.00222.50-1798-0.13%
2024/08/301222.0000.00216.0017920.13%
2024/08/2900.000.1220.50221.00-0.1795-0.01%
2024/08/280.1211.0000.00210.000.17880.01%
2024/08/2300.000.1228.00229.00-0.1798-0.01%
2024/08/2100.000.1224.00225.00-0.1802-0.01%
2024/08/2000.000.1215.27216.00-0.1806-0.01%
2024/08/1600.000.1200.50200.50-0.1822-0.01%
2024/08/0900.0023181.63203.50-23824-2.79%
2024/08/0800.0010186.45187.00-10794-1.26%
2024/08/0712176.9614176.43180.00-2781-0.26%
2024/08/0600.008183.00171.00-8777-1.03%
2024/08/0500.001178.00180.00-1768-0.13%
2024/08/021175.0000.00177.5017490.13%
2024/08/0100.000.1176.50175.50-0.1732-0.01%
2024/07/3100.000.1162.00161.00-0.1727-0.01%
2024/07/260.1147.0000.00148.000.17000.01%
2024/07/230.1159.0000.00160.000.16850.01%
2024/07/1700.000.1190.50191.00-0.1589-0.02%
2024/07/1500.001163.00164.50-1554-0.18%
2024/07/121161.5000.00162.0015440.18%
2024/05/291899.30297.6094.50163195.00%
2024/05/2200.00193.0091.50-1260-0.38%
2024/05/20185.80184.5086.3002380.00%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音